Genix Pharmaceuticals Corporation Agrees To Purchase 30 Ophthalmic Generic Drug Dossiers And Enters Into LOI To Acquire 2 Additional Nutraceutical Products
Vancouver, British Columbia--(Newsfile Corp. - December 23, 2019) - Genix Pharmaceuticals Corp. (TSXV: GENX) ("GENIX" or the "Company"), announces that the Company has entered into an Acquisition Agreement dated for reference September 19, 2019 (the "Agreement") and executed October 9, 2019 with Canagen Pharmaceuticals Inc. ("Canagen") pursuant to which, subject to acceptance of the TSX Venture Exchange ("TSXV"), the Company has agreed to purchase thirty (30) World Health Organization...
2019-12-23 7:13 PM EST
ALTA Announces Name Change to Genix Pharmaceuticals Corporation
Vancouver, British Columbia--(Newsfile Corp. - June 18, 2019) - Alta Natural Herbs & Supplements Ltd. (TSXV: AHS) ("ALTA" or the "Company") is pleased to announce that it will be changing its Corporate name to Genix Pharmaceuticals Corporation effective on the commencement of trading Friday, June 21, 2019. The Company's common shares will trade on the TSX Venture Exchange under the new name and new stock symbol "GENX" on June 21, 2019. The name change, approved at last year's AGM, will...
2019-06-18 6:43 PM EDT
Alta Natural Herbs & Supplements Appoints Board Member
Vancouver, British Columbia--(Newsfile Corp. - June 5, 2019) - Alta Natural Herbs & Supplements (TSXV: AHS) (The "Company" or "ALTA") announces Dr. Conny Lin, PhD., has joined the Board of Directors of the Company effective immediately.Dr. Lin is a neuroscientist, a policy maker, and a veteran in board governance and government funding acquisition. She has started and led numerous organizations in various sectors, spearheading operations, human resources, R&D, and public relations. Dr. Lin...
2019-06-05 4:27 PM EDT
Alta Natural Herbs & Supplements Appoints New Officers and Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - March 11, 2019) - Alta Natural Herbs & Supplements Ltd. (TSXV: AHS) (the "Company" or "AHS") is pleased to announce the appointment of Mr. Sina Pirooz as the new Chief Executive Officer (CEO), and Mr. Jamie Lewin as Chief Financial Officer (CFO) and Director of the Company.Sina Pirooz possesses over 18 years experience in the international pharmaceuticals industry and has been a professional member of the College of Pharmacists of British...
2019-03-11 6:00 AM EDT